Intec Pharma

NTEC NASDAQ
3.180
-0.200
-5.92%
盘后: 3.180 0 0.00% 16:00 07/17 EDT
开盘
3.400
昨收
3.380
最高
3.460
最低
3.155
成交量
19.70万
成交均量(3M)
32.52万
52周最高
9.25
52周最低
3.100
换手率
0.76%
市值
8,291.91万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Intec Pharma NTEC股票价格,Intec Pharma股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson’s disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.
展开 >

最近浏览

名称
价格
涨跌幅